With custom-tailored investment advice, the firm has been a leader in the space for over 90 years. Now, with over 7 million clients, it's no wonder that many of them are beginning to ask questions about cannabis-related investments.
While the report does mention that "there are 80 sites with a license to produce," (which is now 82 sites) it also notes that "there are over 400 sites with license applications in progress." Based on these statistics, the report deems the space to have "low barriers to entry," while failing to mention the hundreds of licensed producer applications that Health Canada has refused.
Edward Jones' Reccomendations
Due to a handful of risks and factors, Ashtyn Evans, CFA and Brittany Weissman, CFA recommend that clients look to companies in the Health Care and Consumer Staples sectors:
We're surprised that the report decided on the companies listed above as ways to gain exposure to the exploding industry, as there are even more logical choices within the pharmaceutical space such as GW Pharmaceuticals Plc (NASDAQ:GWPH) and more.